Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software

NCT07078071 is registered in ClinicalTrials.gov with Huawei Device Co., Ltd as lead sponsor.

NCT NCT07078071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07078071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software
Lead sponsor
Huawei Device Co., Ltd
Phase
Not applicable
Overall status
Completed
Start date
October 18, 2022
Completion date
March 1, 2023
Enrollment
199 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, heart